Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$877K Hold
6,000
0.28% 65
2016
Q3
$1M Hold
6,000
0.27% 60
2016
Q2
$913K Hold
6,000
0.25% 63
2016
Q1
$900K Hold
6,000
0.23% 64
2015
Q4
$974K Hold
6,000
0.25% 60
2015
Q3
$830K Hold
6,000
0.24% 67
2015
Q2
$921K Sell
6,000
-108
-2% -$17.3K 0.27% 66
2015
Q1
$976K Hold
6,108
0.28% 66
2014
Q4
$973K Hold
6,108
0.33% 66
2014
Q3
$858K Hold
6,108
0.29% 71
2014
Q2
$723K Hold
6,108
0.24% 76
2014
Q1
$753K Sell
6,108
-92
-1% -$11.2K 0.25% 73
2013
Q4
$707K Hold
6,200
0.23% 73
2013
Q3
$694K Hold
6,200
0.24% 77
2013
Q2
$612K Buy
+6,200
New +$643K 0.21% 82

Other funds holding AMGN

High Point Bank & Trust's AMGN Position: Q4 2016 in Review

High Point Bank & Trust held its Amgen (AMGN) position steady in Q4 2016 at 6,000 shares worth $877K. The position accounts for 0.28% of the portfolio, ranked #65.

High Point Bank & Trust first reported a position in AMGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $1M in Q3 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • High Point Bank & Trust held 6,000 shares of Amgen worth $877K as of Q4 2016.
  • High Point Bank & Trust left its Amgen share count unchanged in Q4 2016.
  • Amgen made up 0.28% of High Point Bank & Trust's portfolio in Q4 2016, its #65 holding.
  • High Point Bank & Trust first reported a position in Amgen in Q2 2013 and has held it in 15 quarters since.
  • High Point Bank & Trust's Amgen position peaked at $1M in Q3 2016.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on High Point Bank & Trust's 13F filing for Q4 2016, filed 28 Feb 2017.